B2B Software Technologies Ltd

B2B Software Technologies Limited trading window closed from 01.10.2026 till 48 hours after the declaration of Financial Results for the Quarter and Half Year ending on 30.09.2026.

AGM Details

• Date and mode: 28 Aug 2026, VC/OAVM.
• Time: 10:30–11:00 AM.
• Record date: 21 Aug 2026.
• Last date for postal ballots: 28 Aug 2026.
• Shareholders on record: 9,170.

Resolutions & Outcomes

• Resolution 1: Adopt Audited standalone and consolidated financial statements for year ended March 31, 2026; Passed.
• Resolution 2: Appointment of Dr. Yaramati Avinash as director on rotation and for re-appointment; Passed.
• Resolution 3: Re-appoint M. V. Vijaya Kumar & Co. as Statutory Auditors; Passed.
• Resolution 4: Re-appointment of Bala Subramanyam Vanapalli as Whole-Time Director; Passed.
• Resolution 5: Approve performance bonus for Whole-Time Director for FY2025-26; Passed.

Governance Changes

• Director changes: Dr. Yaramati Avinash appointed; Bala Subramanyam Vanapalli re-appointed as WTD.
• Auditor changes: M. V. Vijaya Kumar & Co. re-appointed as Statutory Auditors.
• Remuneration: Performance bonus approved for WTD for FY2025-26.

RPTs & Other Approvals

• Material related party transactions: None disclosed in the notice.
• Dividend: Not discussed or declared at AGM.

AGM details

• 32nd AGM held on 28 August 2026 at 10:30 a.m. via video conference.
• Meeting concluded at 11:00 a.m.
• Quorum of 67 members attended.

Key resolutions

• Adopt audited financial statements, directors' report, and auditors' report for FY2025-26.
• Re-appoint Dr. Yaramati Avinash by rotation.
• Re-appoint M/s M. V. Vijaya Kumar & Co. as statutory auditors for five years.
• Re-appoint Bala Subramanyam Vanapalli as Whole-Time Director.
• Approve performance bonus for Bala Subramanyam Vanapalli for FY2025-26.

Voting status / outcomes

• Results of remote and AGM voting to be disseminated to BSE and the company website.
• E-voting at AGM conducted; 15-minute window after meeting.

Directors

• Dr. Yaramati Avinash to be re-appointed by rotation.
• Bala Subramanyam Vanapalli re-appointed as Whole-Time Director.

Auditors

• Statutory auditors M/s M. V. Vijaya Kumar & Co. appointed for five years.

Remuneration approvals

• Approval of performance bonus for Bala Subramanyam Vanapalli for FY2025-26.

AGM notice details

• 32nd AGM for FY2025-26 to be held on 28 Aug 2026 via VC/OAVM.
• Notice and Integrated Annual Report circulated electronically to members on 05 Aug 2026.
• Remote e-voting from 25 Aug 2026 09:00 to 27 Aug 2026 17:00; cut-off 21 Aug 2026.
• Access to notices and annual report via company website and CDSL platform.
• Newspaper notice published on 6 Aug 2026 in Financial Express and Mana Telangana.

Financial snapshot

• Standalone revenue Rs 1,607.29 L; YoY +6%.
• Consolidated revenue Rs 3,045.58 L; YoY +20%.
• Standalone PAT Rs 230.18 L; Consolidated PAT Rs 284.28 L.
• Standalone PBT Rs 330.16 L; Consolidated PBT Rs 384.25 L.
• Standalone basic EPS Rs 1.99; Consolidated basic EPS Rs 2.45.
• Interim dividend Rs 1 per share declared; no final dividend.

Geography and segments

• India revenue Rs 1,607.29 L; USA Rs 1,438.30 L; total Rs 3,045.58 L.
• Strategy centers on Healthcare, Emerging Tech, and ERP.
• Publishing Industry vertical progress on Microsoft AppSource.
• Consolidated segment assets: India 2,607.99 L; USA 214.59 L.

Capital and liquidity

• No outstanding debt; debt-to-equity zero.
• Interim dividend paid; no final dividend.
• Authorized share capital raised to Rs 18 Cr; post-year-end bonus adjustments.

ESOPs and capital movements

• Three ESOP grants; 2,60,755 options exercised in FY2025-26.
• Grant 3: 24,811 options outstanding; vesting in one year.
• Exercise price Rs 10; fair value Rs 23.92 for options.

Strategy and growth outlook

• Three verticals: Healthcare, Emerging Technologies, and ERP.
• Emerging Technologies capex Rs 1 crore; launched Sep 2025.
• ERP remains cash-generative; IP-led verticals to offset margin pressure.
• Outlook: AI/ML and cloud focus to drive growth and margins.

Governance and leadership

• Board of five; Dr. Y. Avinash appointed Addl. Non-Executive Director July 2025; regularized Sept 2025.
• Company Secretary changes: Maddukuri resigned Aug 2025; Yamini Saini appointed Apr 2026; Unnati Rathi appointed Jul 2026.
• Auditors: MVV Kumar & Co proposed for five-year term 2026-32; annual fee Rs 2.20 L.
• Independent Director meeting held Feb 23, 2026; board evaluation completed.

Subsidiaries and related parties

• Subsidiary: B2B Softech Inc., USA; turnover Rs 1,438.30 L; PAT Rs 54.10 L.
• Genius Doc Inc.: exports Rs 399.59 L; Antelope Valley Cancer Center: exports Rs 103.93 L.
• All related party transactions are arm's length and disclosed in Form AOC-2.

AGM Details

• AGM scheduled for 28 August 2026 at 10:30 AM via VC/OAVM.
• Cut-off date for voting: 21 August 2026.
• Annual report dispatched 5 August 2026; deemed venue at registered office.

Resolutions

• Item 1 (Ordinary): Adoption of Audited Standalone and Consolidated financial statements.
• Item 2 (Ordinary): Re-appointment of Dr. Yaramati Avinash as director by rotation.
• Item 3 (Ordinary): Re-appointment of M/s MV Vijaya Kumar & Co. as statutory auditors for five years; remuneration Rs 2,20,000.
• Item 4 (Special): Re-appointment of Bala Subramanyam Vanapalli as Whole-time Director for 3 years; Rs 2,50,000 per month; including perquisites.
• Item 5 (Special): Approval for payment of performance bonus to WTD for FY 2025-26: Rs 20,76,909.

Dividend

• Interim dividend of Rs 1 per equity share declared in the year; final dividend not proposed.

Director Changes

• Dr. Yaramati Avinash appointed Addl. Non-Executive Director on 12.07.2025; regularized 29.09.2025.
• Mr. Yaramati Satyanarayana resigned as Non-Executive Director on 12.07.2025.
• Ms. Gita Usha Rani Maddukuri appointed CS & Compliance Officer 01.04.2025; resigned 26.08.2025.
• Ms. Yamini Saini appointed CS & Compliance Officer 22.04.2026; resigned 17.07.2026.
• Ms. Unnati Rathi appointed CS & Compliance Officer 17.07.2026.

Auditors

• Jawahar & Associates ceased as statutory auditor on 12.08.2025.
• M/s MV Vijaya Kumar & Co. proposed as statutory auditors for 5-year term (2026-27 to 2030-31) at Rs 2.20 lakh p.a.
• Internal Auditor: Ms. Srijani Sarkar; Secretarial Auditor: DSMR & Associates.

Related Party Transactions

• Genius Doc Inc. (Export of software services): Rs 399.59 Lakhs.
• Antelope Valley Cancer Center (Export of software services): Rs 103.93 Lakhs.
• Remuneration to KMP: Bala 51.04; Ram Nemani 36.00; Sunil Nemani 12.00; CS 1.53.
• Outstanding balance: Managerial remuneration payable to KMP Rs 6.50.

Other Material Approvals

• ESOP Scheme 2024: three grants; total options ~5.77 Lakh; 2.60 Lakh exercised in FY2025-26.
• Bonus issue approved via Postal Ballot; 1:2 ratio; allotment completed 2–6 Apr 2026; listing approvals obtained.

Financial results

• Unaudited standalone Q1 FY2026 revenue from operations: 364.98 lakh.
• Standalone Q1 FY2026 profit after tax: 63.10 lakh; EPS 0.36.
• Consolidated Q1 FY2026 revenue from operations: 738.99 lakh; PAT 91.61 lakh; EPS 0.55.
• Bonus issue: 1:2 equity shares; allotment completed by 6 April 2026.
• Limited Review Reports on standalone and consolidated Q1 FY2026 submitted.

Governance & appointments

• Ms Yamini Saini resigned as Company Secretary & Compliance Officer effective 17 July 2026.
• Ms Unnati Rathi appointed CS & Compliance Officer w.e.f. 17 July 2026.
• Mr Bala Subramanyam Vanapalli re-appointed Whole-Time Director from 01 Oct 2026 for 3 years.
• M/s MV Vijaya Kumar & Co. re-appointed as Statutory Auditors for second term of 5 years.
• AGM for FY2025-26 scheduled on 28 August 2026 at 10:30 AM via VC/OAVM.

Meeting Details

• Date: 17 July 2026; Time: not disclosed; Location: registered office of the Company.

Key Agenda Items

• Consider unaudited standalone and consolidated financial statements for the quarter ended June 30, 2026.
• Limited Review Report for the quarter ended June 30, 2026.

Demat/Remat status

• Securities received for dematerialisation were accepted/rejected and listed on exchanges.

Certificate handling

• Dematerialisation certificates were mutilated and cancelled after verification, with depository name substituted as registered owner.

CDSL confirmations

• CDSL demat confirmations were not received during the period.